Republished research: Impact of autologous blood injections in treatment of mid-portion Achilles tendinopathy: double blind randomised controlled trial
- PMID: 25114183
- DOI: 10.1136/bjsports-2013-f2310rep
Republished research: Impact of autologous blood injections in treatment of mid-portion Achilles tendinopathy: double blind randomised controlled trial
Abstract
Study question: Do peritendinous autologous blood injections improve pain and function in people with mid-portion Achilles tendinopathy?
Summary answer: The administration of two unguided peritendinous autologous blood injections one month apart, in addition to a standardised eccentric training programme, provides no additional benefit in the treatment of mid-portion Achilles tendinopathy.
What is known and what this paper adds: Several studies have suggested that injection of autologous blood can help in the treatment of various tendinopathies. There is a lack of high quality evidence showing relevant benefit for autologous blood injections, particularly in the management of mid-portion Achilles tendinopathy. We found no additional reduction in pain or improvement in function when these injections were combined with an eccentric calf training programme.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Republished from
-
Impact of autologous blood injections in treatment of mid-portion Achilles tendinopathy: double blind randomised controlled trial.BMJ. 2013 Apr 18;346:f2310. doi: 10.1136/bmj.f2310. BMJ. 2013. PMID: 23599320 Free PMC article. Clinical Trial.
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources